Brokerages Set Sotera Health (NASDAQ:SHC) PT at $16.08

Shares of Sotera Health (NASDAQ:SHC) have received an average recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $16.08.

A number of brokerages have recently commented on SHC. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Citigroup upped their price objective on Sotera Health from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, November 6th. Finally, The Goldman Sachs Group started coverage on Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 target price on the stock.

Institutional Trading of Sotera Health

Institutional investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD increased its holdings in Sotera Health by 25.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 59,480 shares of the company’s stock valued at $715,000 after buying an additional 12,195 shares in the last quarter. Comerica Bank raised its holdings in Sotera Health by 20.1% during the first quarter. Comerica Bank now owns 48,179 shares of the company’s stock worth $579,000 after purchasing an additional 8,074 shares during the last quarter. CWM LLC raised its holdings in Sotera Health by 86.1% during the second quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares during the last quarter. Simplicity Wealth LLC purchased a new stake in Sotera Health during the second quarter worth $128,000. Finally, Wedmont Private Capital acquired a new stake in Sotera Health in the second quarter valued at $127,000. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Sotera Health Trading Up 0.5 %

NASDAQ:SHC opened at $13.26 on Monday. The company has a market capitalization of $3.76 billion, a PE ratio of 52.20 and a beta of 1.96. Sotera Health has a 52-week low of $10.71 and a 52-week high of $17.44. The stock’s 50 day moving average price is $14.76 and its 200 day moving average price is $14.14. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business had revenue of $285.47 million for the quarter, compared to analysts’ expectations of $278.64 million. During the same quarter last year, the business posted $0.18 earnings per share. The business’s revenue was up 8.5% on a year-over-year basis. On average, research analysts anticipate that Sotera Health will post 0.61 EPS for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.